<DOC>
	<DOCNO>NCT00727961</DOCNO>
	<brief_summary>The aim study evaluate efficacy tolerability , number positive response treatment CAELYX ( 50 mg/m^2 ) , administer monotherapy per 4 week patient metastatic epithelial ovarian cancer , resistant previous platinum therapy .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Tolerance Caelyx Patients With Epithelial Ovarian Cancer . ( Study P04072 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<criteria>Subjects must demonstrate willingness participate study comply procedure sign write informed consent and/or parent legal guardian must sign write informed consent . Women must great equal 18 year age , race . Women childbearing potential ( include woman less 1 year postmenopausal woman become sexually active ) must use acceptable method birth control ( e.g. , hormonal contraceptive , medically prescribe IUD , condom combination spermicide ) surgically sterilize ( e.g. , hysterectomy tubal ligation ) . Morphology ( cytology histology ) confirm diagnosis epithelial ovarian cancer . Patients 1 measurable and/or evaluable tumor , accord result CT , MRT scan Xray , etc . Patients , include primary surgical treatment , previously receive platinum chemotherapy secondline therapy indicate . Karnofsky performance status 60 % . Left ventricular ejection fraction 50 % ( accord result echocardiography ) . Adequate bone marrow function indicate : Platelets &gt; 100x10^9/L Haemoglobin &gt; 9 g/dL Absolute neutrophil count &gt; 1.5x10^9/L Adequate renal function indicate : Serum creatinine &lt; 1.5 х ULN Adequate liver function indicate : Bilirubin level AST ALT activity &lt; 2 х ULN ( exception case related primary disease ) . Women pregnant nursing . Subjects observed designate washout period prohibit medication . Subjects use investigational product within 30 day prior enrollment . Medical history indicate serious concomitant disease , congestive heart failure II NYHA class high , insulindependent diabetes mellitus , clinically significant liver disease , mental disorder . Noncontrolled bacterial , viral fungal infection . Conditions reason ( medical , social psychological ) might prevent adequate followup patient . Any active primary tumor treatment ( except basal squamous cell carcinoma situ cervix carcinoma ) . Patient symptomatic metastasis brain .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>